Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Reed

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
International Journal of Cancer|January 10, 2008
17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancerJoanna M Day, Paul A Foster, Helena J Tutill, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitorSusannah J Stanway, Atul Purohit, L W Lawrence Woo, et al.
Chemical Communications (Cambridge, England)|April 14, 2010
Chimeric microtubule disruptorsMathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Journal of Medicinal Chemistry|February 12, 2008
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agentsMathew P Leese, Fabrice L Jourdan, Keira Gaukroger, et al.
Gene Regulation and Systems Biology|August 15, 2017
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque CharacteristicsJeffrey E Ming, Ruth E Abrams, Derek W Bartlett, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
International Journal of Cancer|January 10, 2008
17beta-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancerJoanna M Day, Paul A Foster, Helena J Tutill, et al.
Molecular Cancer Therapeutics|August 30, 2008
Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated second-generation agent, in vitro and in vivo activities, molecular modeling, and protein crystallographyL W Lawrence Woo, Delphine S Fischer, Christopher M Sharland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitorSusannah J Stanway, Atul Purohit, L W Lawrence Woo, et al.
Chemical Communications (Cambridge, England)|April 14, 2010
Chimeric microtubule disruptorsMathew P Leese, Fabrice Jourdan, Meriel R Kimberley, et al.
Journal of Medicinal Chemistry|February 12, 2008
Structure-activity relationships of C-17 cyano-substituted estratrienes as anticancer agentsMathew P Leese, Fabrice L Jourdan, Keira Gaukroger, et al.
Gene Regulation and Systems Biology|August 15, 2017
A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque CharacteristicsJeffrey E Ming, Ruth E Abrams, Derek W Bartlett, et al.
Pageof 8